PTCT: Ptc Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Ptc Therapeutics Inc (PTCT).
$3.48B Market Cap.
PTCT Market Cap. (MRY)
PTCT Shares Outstanding (MRY)
PTCT Assets (MRY)
Total Assets
$1.71B
Total Liabilities
$2.80B
Total Investments
$359.99M
PTCT Income (MRY)
Revenue
$806.78M
Net Income
-$363.30M
Operating Expense
$1.06B
PTCT Cash Flow (MRY)
CF Operations
-$107.69M
CF Investing
$44.18M
CF Financing
$255.87M
PTCT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,705,024,000 (-10.06%) | $1,895,698,000 (11.14%) | $1,705,619,000 (-11.99%) | $1,938,056,000 (-12.24%) |
Assets Current | $1,365,531,000 (12.05%) | $1,218,629,000 (75.65%) | $693,785,000 (-27.30%) | $954,368,000 (-22.52%) |
Assets Non-Current | $339,493,000 (-49.86%) | $677,069,000 (-33.08%) | $1,011,834,000 (2.86%) | $983,688,000 (0.73%) |
Goodwill & Intangible Assets | $201,135,000 (-56.45%) | $461,838,000 (-41.41%) | $788,232,000 (-2.35%) | $807,182,000 (1.19%) |
Shareholders Equity | -$1,098,071,000 (-34.15%) | -$818,555,000 (-135.84%) | -$347,086,000 (-24236.72%) | $1,438,000 (-99.70%) |
Property Plant & Equipment Net | $117,655,000 (-34.27%) | $178,985,000 (2.27%) | $175,020,000 (34.62%) | $130,006,000 (9.95%) |
Cash & Equivalents | $779,709,000 (31.26%) | $594,001,000 (112.27%) | $279,834,000 (47.50%) | $189,718,000 (-9.14%) |
Accumulated Other Comprehensive Income | -$25,886,000 (-1914.47%) | -$1,285,000 (-126.79%) | $4,796,000 (119.75%) | -$24,282,000 (60.17%) |
Deferred Revenue | $5,505,000 (587.27%) | $801,000 (-40.71%) | $1,351,000 (0%) | $0 (0%) |
Total Investments | $359,987,000 (27.32%) | $282,738,000 (116.04%) | $130,871,000 (-77.58%) | $583,658,000 (-34.78%) |
Investments Current | $359,987,000 (27.32%) | $282,738,000 (116.04%) | $130,871,000 (-77.58%) | $583,658,000 (-34.78%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $23,194,000 (-24.15%) | $30,577,000 (40.21%) | $21,808,000 (37.54%) | $15,856,000 (-15.19%) |
Trade & Non-Trade Receivables | $158,554,000 (-1.41%) | $160,822,000 (3.35%) | $155,614,000 (40.88%) | $110,455,000 (57.95%) |
Trade & Non-Trade Payables | $305,092,000 (-28.76%) | $428,283,000 (-11.58%) | $484,366,000 (-8.38%) | $528,684,000 (9.56%) |
Accumulated Retained Earnings (Deficit) | -$3,646,873,000 (-11.06%) | -$3,283,578,000 (-23.58%) | -$2,656,974,000 (-26.65%) | -$2,097,957,000 (-28.80%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $55,905,000 (-45.64%) | $102,834,000 (-25.00%) | $137,110,000 (0.27%) |
Total Debt | $389,296,000 (-6.20%) | $415,026,000 (-41.02%) | $703,627,000 (31.43%) | $535,379,000 (27.34%) |
Debt Current | $13,363,000 (-16.49%) | $16,002,000 (29.36%) | $12,370,000 (-92.26%) | $159,813,000 (1728.31%) |
Debt Non-Current | $375,933,000 (-5.79%) | $399,024,000 (-42.28%) | $691,257,000 (84.06%) | $375,566,000 (-8.78%) |
Total Liabilities | $2,803,095,000 (3.27%) | $2,714,253,000 (32.23%) | $2,052,705,000 (5.99%) | $1,936,618,000 (12.18%) |
Liabilities Current | $580,981,000 (-3.67%) | $603,100,000 (48.46%) | $406,236,000 (-20.24%) | $509,348,000 (83.66%) |
Liabilities Non-Current | $2,222,114,000 (5.26%) | $2,111,153,000 (28.22%) | $1,646,469,000 (15.36%) | $1,427,270,000 (-1.50%) |
PTCT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $806,780,000 (-13.97%) | $937,822,000 (34.20%) | $698,801,000 (29.75%) | $538,593,000 (41.45%) |
Cost of Revenue | $57,398,000 (-12.35%) | $65,486,000 (46.57%) | $44,678,000 (38.20%) | $32,328,000 (70.67%) |
Selling General & Administrative Expense | $300,911,000 (-9.51%) | $332,540,000 (2.01%) | $325,998,000 (14.08%) | $285,773,000 (16.56%) |
Research & Development Expense | $534,480,000 (-19.82%) | $666,563,000 (2.31%) | $651,496,000 (20.49%) | $540,684,000 (13.20%) |
Operating Expenses | $1,056,427,000 (-26.61%) | $1,439,538,000 (27.68%) | $1,127,432,000 (27.94%) | $881,208,000 (14.40%) |
Interest Expense | $166,993,000 (29.27%) | $129,180,000 (42.16%) | $90,871,000 (5.64%) | $86,022,000 (52.65%) |
Income Tax Expense | $176,000 (100.25%) | -$69,506,000 (-144.14%) | -$28,470,000 (-611.96%) | $5,561,000 (-84.21%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$363,295,000 (42.02%) | -$626,604,000 (-12.09%) | -$559,017,000 (-6.70%) | -$523,901,000 (-19.57%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$363,295,000 (42.02%) | -$626,604,000 (-12.09%) | -$559,017,000 (-6.70%) | -$523,901,000 (-19.57%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$363,295,000 (42.02%) | -$626,604,000 (-12.09%) | -$559,017,000 (-6.70%) | -$523,901,000 (-19.57%) |
Weighted Average Shares | $76,845,055 (2.68%) | $74,838,392 (4.34%) | $71,728,634 (1.79%) | $70,466,393 (6.72%) |
Weighted Average Shares Diluted | $76,845,055 (2.68%) | $74,838,392 (4.34%) | $71,728,634 (1.79%) | $70,466,393 (6.72%) |
Earning Before Interest & Taxes (EBIT) | -$196,126,000 (65.41%) | -$566,930,000 (-14.16%) | -$496,616,000 (-14.87%) | -$432,318,000 (-24.74%) |
Gross Profit | $749,382,000 (-14.09%) | $872,336,000 (33.36%) | $654,123,000 (29.21%) | $506,265,000 (39.92%) |
Operating Income | -$307,045,000 (45.87%) | -$567,202,000 (-19.84%) | -$473,309,000 (-26.23%) | -$374,943,000 (8.21%) |
PTCT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $44,182,000 (125.00%) | -$176,737,000 (-160.91%) | $290,181,000 (32.39%) | $219,182,000 (139.03%) |
Net Cash Flow from Financing | $255,866,000 (-60.42%) | $646,400,000 (284.87%) | $167,952,000 (704.48%) | $20,877,000 (-96.88%) |
Net Cash Flow from Operations | -$107,688,000 (32.02%) | -$158,418,000 (55.58%) | -$356,654,000 (-41.91%) | -$251,332,000 (-29.51%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $185,032,000 (-41.14%) | $314,359,000 (218.48%) | $98,707,000 (616.95%) | -$19,094,000 (75.90%) |
Net Cash Flow - Business Acquisitions and Disposals | -$57,747,000 (35.54%) | -$89,587,000 (25.62%) | -$120,444,000 (-110.50%) | -$57,218,000 (-50.04%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$69,625,000 (-18.59%) | -$58,712,000 (-113.26%) | $442,641,000 (45.31%) | $304,613,000 (160.25%) |
Capital Expenditure | $171,554,000 (703.26%) | -$28,438,000 (11.18%) | -$32,016,000 (-13.48%) | -$28,213,000 (-58.12%) |
Issuance (Repayment) of Debt Securities | -$1,490,000 (99.61%) | -$383,594,000 (-379.44%) | $137,270,000 (6272.21%) | -$2,224,000 (95.24%) |
Issuance (Purchase) of Equity Shares | $33,764,000 (12.57%) | $29,994,000 (-57.80%) | $71,082,000 (207.70%) | $23,101,000 (-77.70%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$7,328,000 (-335.32%) | $3,114,000 (212.34%) | -$2,772,000 (64.56%) | -$7,821,000 (-201.73%) |
Share Based Compensation | $74,615,000 (-26.59%) | $101,636,000 (-7.88%) | $110,333,000 (6.59%) | $103,513,000 (47.19%) |
Depreciation Amortization & Accretion | $83,415,000 (-66.15%) | $246,417,000 (77.64%) | $138,720,000 (93.96%) | $71,520,000 (-21.37%) |
PTCT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 92.90% (-0.11%) | 93.00% (-0.64%) | 93.60% (-0.43%) | 94.00% (-1.05%) |
Profit Margin | -45.00% (32.63%) | -66.80% (16.50%) | -80.00% (17.78%) | -97.30% (15.46%) |
EBITDA Margin | -14.00% (59.06%) | -34.20% (33.20%) | -51.20% (23.58%) | -67.00% (0.15%) |
Return on Average Equity (ROAE) | 36.10% (-63.61%) | 99.20% (-62.44%) | 264.10% (175.05%) | -351.90% (-320.43%) |
Return on Average Assets (ROAA) | -20.00% (51.34%) | -41.10% (-26.46%) | -32.50% (-25.97%) | -25.80% (-9.32%) |
Return on Sales (ROS) | -24.30% (59.83%) | -60.50% (14.91%) | -71.10% (11.46%) | -80.30% (11.76%) |
Return on Invested Capital (ROIC) | -30.90% (56.29%) | -70.70% (-16.47%) | -60.70% (-69.55%) | -35.80% (0.56%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -9.54 (-189.80%) | -3.29 (32.80%) | -4.9 (8.60%) | -5.36 (41.67%) |
Price to Sales Ratio (P/S) | 4.3 (95.54%) | 2.2 (-43.87%) | 3.92 (-24.81%) | 5.21 (-50.76%) |
Price to Book Ratio (P/B) | -3.17 (-24.75%) | -2.54 (67.86%) | -7.91 (-100.40%) | 1,958.2 (22564.40%) |
Debt to Equity Ratio (D/E) | -2.55 (23.01%) | -3.32 (43.93%) | -5.91 (-100.44%) | 1,346.74 (37497.54%) |
Earnings Per Share (EPS) | -4.73 (43.49%) | -8.37 (-7.45%) | -7.79 (-4.85%) | -7.43 (-11.90%) |
Sales Per Share (SPS) | 10.5 (-16.22%) | 12.53 (28.63%) | 9.74 (27.46%) | 7.64 (32.53%) |
Free Cash Flow Per Share (FCFPS) | 0.83 (133.28%) | -2.5 (53.92%) | -5.42 (-36.60%) | -3.97 (-23.62%) |
Book Value Per Share (BVPS) | -14.29 (-30.64%) | -10.94 (-126.04%) | -4.84 (-24295.00%) | 0.02 (-99.73%) |
Tangible Assets Book Value Per Share (TABVPS) | 19.57 (2.15%) | 19.16 (49.80%) | 12.79 (-20.30%) | 16.05 (-24.88%) |
Enterprise Value Over EBIT (EV/EBIT) | -17 (-240.00%) | -5 (16.67%) | -6 (14.29%) | -7 (41.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -29.77 (-264.36%) | -8.17 (4.25%) | -8.53 (2.61%) | -8.76 (45.96%) |
Asset Turnover | 0.45 (-27.64%) | 0.61 (51.48%) | 0.41 (53.21%) | 0.27 (29.27%) |
Current Ratio | 2.35 (16.28%) | 2.02 (18.33%) | 1.71 (-8.86%) | 1.87 (-57.80%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $63,866,000 (134.18%) | -$186,856,000 (51.92%) | -$388,670,000 (-39.04%) | -$279,545,000 (-31.91%) |
Enterprise Value (EV) | $3,355,632,955 (28.13%) | $2,618,961,276 (-14.25%) | $3,054,339,619 (-3.39%) | $3,161,618,357 (-23.72%) |
Earnings Before Tax (EBT) | -$363,119,000 (47.84%) | -$696,110,000 (-18.49%) | -$587,487,000 (-13.34%) | -$518,340,000 (-28.64%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$112,711,000 (64.83%) | -$320,513,000 (10.45%) | -$357,896,000 (0.80%) | -$360,798,000 (-41.14%) |
Invested Capital | $532,495,000 (-18.30%) | $651,785,000 (-30.29%) | $934,944,000 (-3.33%) | $967,187,000 (-28.08%) |
Working Capital | $784,550,000 (27.46%) | $615,529,000 (114.06%) | $287,549,000 (-35.39%) | $445,020,000 (-53.37%) |
Tangible Asset Value | $1,503,889,000 (4.88%) | $1,433,860,000 (56.30%) | $917,387,000 (-18.88%) | $1,130,874,000 (-19.83%) |
Market Capitalization | $3,481,428,955 (67.40%) | $2,079,764,276 (-24.20%) | $2,743,737,619 (-2.56%) | $2,815,897,357 (-32.38%) |
Average Equity | -$1,006,630,000 (-59.39%) | -$631,548,500 (-198.33%) | -$211,697,250 (-242.19%) | $148,879,250 (-71.56%) |
Average Assets | $1,813,311,000 (18.86%) | $1,525,636,500 (-11.37%) | $1,721,416,250 (-15.16%) | $2,028,997,750 (9.50%) |
Invested Capital Average | $634,090,250 (-20.92%) | $801,875,500 (-1.91%) | $817,478,500 (-32.34%) | $1,208,291,750 (25.34%) |
Shares | 77,125,143 (2.20%) | 75,463,145 (4.98%) | 71,882,044 (1.67%) | 70,697,900 (3.61%) |
